![]() ![]() Genomic Health: - Genomic Health is a leading provider of genomic-based diagnostic tests for cancer, including tests for breast, prostate, and colon cancer. ![]() ![]() ěecton, Dickinson, and Company (BD): - BD is a global medical technology company that offers a range of diagnostic products, including molecular diagnostics for infectious diseases and oncology.ĝanaher Corporation: - Danaher is a diversified technology company with a strong presence in the diagnostics market, including molecular diagnostics for infectious diseases, oncology, and genetics.ěio-Rad Laboratories: - Bio-Rad is a global leader in life science research and diagnostics, with a broad portfolio of molecular diagnostic products for infectious diseases, oncology, and genetics.Hologic: Hologic is a leading provider of diagnostic and surgical products, with a strong focus on women's health, including molecular diagnostics for HPV and STIs.QIAGEN: - QIAGEN is a leading provider of sample and assay technologies for molecular diagnostics, with a focus on infectious diseases, oncology, and precision medicine.Thermo Fisher Scientific: - Thermo Fisher Scientific is a leading provider of laboratory equipment, reagents, and software, with a strong presence in the molecular diagnostics market.Ěbbott Laboratories: - Abbott is a global healthcare company that offers a wide range of diagnostic products, including molecular diagnostics for infectious diseases and oncology.Roche Diagnostics: - Roche is one of the largest players in the molecular diagnostics market, with a broad range of products in areas such as oncology, infectious diseases, and genetics.PUNE, MAHARASHTRA, INDIA, Febru/ / - According to a new report published by Allied Market Research, titled, “Molecular Diagnostics, by Product Type, Technology, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2021–2030," the global Molecular Diagnostics Market Size was valued at USD 9.16 billion in 2020 and is Anticipated to Garner USD 23.90 billion by 2030 registering a CAGR of 9.86% from 2021 to 2030. Increase in the prevalence of infectious diseases and various types of cancer drives the growth of the molecular diagnostics market. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |